Hypertension and breast cancer: An association revisited?

Journal of Human Hypertension

Volumn 20, Issue 10, 2006, Pages 722-724

  Goon, P K Y ^a   Messerli, F H ^b   Lip, G Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; RESERPINE; THIAZIDE DIURETIC AGENT;

BODY MASS; BREAST CANCER; BREAST CARCINOMA; CANCER RISK; CASE CONTROL STUDY; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG CHOICE; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; LONG TERM CARE; META ANALYSIS; MORTALITY; NOTE; OBESITY; PRACTICE GUIDELINE; PRESCRIPTION; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; SYSTOLIC HYPERTENSION; TREATMENT DURATION;

AGE FACTORS; AGED; BREAST NEOPLASMS; DIURETICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MIDDLE AGED; PREGNANCY; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 33748923979     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002053     Document Type: Note

References (24)

1. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350(9080): 757-764.
2. Lindholm LH, Anderson H, Ekbom T, Hansson L, Lanke J, Dahlof B et al. Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: A 5-year, prospective, randomised, controlled trial. Lancet 2001; 358(9281): 539-544.
3. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet 2005; 366(9489): 895-906.
4. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265(24): 3255-3264.
5. Dyer AR, Stamler J, Berkson DM, Lindberg HA, Stevens E. High blood-pressure: A risk factor for cancer mortality? Lancet 1975; 1(7915): 1051-1056.
6. Boston Collaborative Drug Surveillance Program. Reserpine and breast cancer: Report from the Boston Collaborative Drug Surveillance Program. Lancet 1974; 2: 669-671.
7. Armstrong B, Stevens N, Doll R. Retrospective study of the association use of rauwolfia derivative and breast cancer in English women. Lancet 1974; 2: 672-675.
8. Heinonen OP, Shapiro S, Tuominen L, Turunen MI. Reserpine use in relation to breast cancer. Lancet 1974; 2: 675-677.
9. Grossman E, Messerli FH, Goldbourt U. Antihypertensive therapy and the risk of malignancies. Eur Heart J 2001; 22: 1343-1352.
10. Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J, Leighton N et al. Hypertension, diuretics and breast cancer risk. J Hum Hypertens 2006; 20(10): 727-732 (this issue).
11. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348(17): 1625-1638.
12. Lindgren AM, Nissinen AM, Tuomilehto JO, Pukkala E. Cancer pattern among hypertensive patients in North Karelia, Finland. J Hum Hypertens 2005; 19(5): 373-379.
13. Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer 2003; 98(7): 1504-1513.
14. Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, la Vecchia C. Hypertension and hormone-related neoplasms in women. Hypertension 1999; 34(2): 320-325.
15. Land CE, Hayakawa N, Machado SG, Yamada Y, Pike MC, Akiba S et al. A case-control interview study of breast cancer among Japanese A-bomb survivors. II. Interactions with radiation dose. Cancer Causes Control 1994; 5(2): 167-176.
16. de Waard F, Baanders-van Halewijn EA. A prospective study in general practice on breast-cancer risk in postmenopausal women. Int J Cancer 1974; 14(2): 153-160.
17. Tornberg SA, Holm LE, Cartensen JM. Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight and blood pressure. Acta Oncol 1988; 27: 31-37.
18. Manjer J, Kaaks R, Riboli E, Berglund G. Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: A prospective study within the Malmo Preventive Project. Eur J Cancer Prev 2001; 10: 33-42.
19. Peeters PH, van Noord PA, Hoes AW, Fracheboud J, Gimbrere CH, Grobbee DE. Hypertension and breast cancer risk in a 19 year follow-up (DOM cohort). J Hypertens 2000; 18: 249-254.
20. Lindgren AM, Nissinen AM, Tuomilehto JO, Pukkala E. Cancer pattern among hypertensive patients in North Karelia, Finland. J Hum Hypertens 2005; 19: 373-379.
21. Grossman E, Messerli FH, Boyko V, Goldbourt U. Is there an association between hypertension and cancer mortality? Am J Med 2002; 112(6): 479-486.
22. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997.
23. Messerli FH. Risk factors for renal cell carcinoma: Hypertension or diuretics? [Editorial]. Kidney Int 2005; 67(2): 774-775.
24. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF et al. Guidelines for management of hypertension: Report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18(3): 139-185.